TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Pharmacokinetic analysis of plasma and urine concentration data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3D intra-oral volume changes in mucosal soft tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Entamoeba histolytica infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: overall therapeutic success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician-Administered PTSD Scale for the DSM-5 (CAPS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Urogynecological symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in Muscle Weakness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: ACE2 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete response without vomiting or use of rescue medications
Endpoint domain: Adverse events/effects
Primary endpoint: COVID-19 related urgent care visit, emergency room assessment, hospitalization or death by Day 28
Endpoint domain: Mortality/survival
Primary endpoint: SARS-CoV-2 RNA negativity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Treatment-emergent and treatment-related serious adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Physical examination of the major organ systems
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Monitoring of Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Single Leg Stance Test - SLS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Five Times Sit to Stance Test - 5XSST
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Romberg Test - RT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Katz Index of Independence in Activities on Daily Living
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Time spent by Healthcare Providers
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Assessment of global disorders
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of oxygen desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: pain status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: level of mobility
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Critical closing pressure of the VAS (Pcrit)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Oxygen withdrawal time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vulvovaginal atrophy improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of rational and irrational beliefs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Levels of emotion-regulation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Levels of child behavioral difficulties
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Rates of RNFL-GCIPL thinning
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Improvement in nighttime GERD-related symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Trunk control measurement scale (TCMS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2D video-based gait assessment system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients with reflux esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Static balance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait speed test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life: (OPQOL 35)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Change from Baseline of BMI after Initiation of ART Therapy at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change of BMI Category after Initiation of ART Therapy at Week 48
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in Regional Lean and Body Mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in post-injection pain at 5 minutes using the Short Form McGill Pain Questionnaire Present Pain Intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in post-injection pain at 5 minutes using the Wong-Baker Faces pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in post-injection pain at 6 hours using the Short Form McGill Pain Questionnaire Present Pain Intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in post-injection pain at 24 hours using the Short Form McGill Pain Questionnaire Present Pain Intensity score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma alpha Glutathione S transferase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Time for 2 segment regression of sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean Blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: ObsQoR-10 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perceived toxicity of the treatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of life Cancer Survivor (QOL-CS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Plasma concentration of testosterone
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Androgen Deprivation Therapy (ADT)-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Patient Pre-Operative Anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pocket resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Anxio-depressive symptomatologic assessments
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Dynamic Balance Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Active repositioning accuracy of ankle joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in alpha and beta bacterial diversity measures in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in Short Chain Fatty Acid (SCFA) levels in stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in total alcohol consumption
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Youth Services Satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of patients with disease flare
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of the Choice-ICD intervention
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Acceptability of the Choice-ICD intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usability of the Choice-ICD intervention
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Vertical-Jump Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Strength (1RM, 1 Repetition Maximum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 100m Sprint Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrarater reliability of 100-mm VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interrater reliability of 100-mm VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrarater reliability of Rutgeerts score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Tolerated Dose (MTD) of single-fraction radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from transplantation to resumption of menses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Mothers' Milk at Discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved patient function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved patient pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients that survive to hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: total pCR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline on the Emotion dysregulation Index (EDI)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of Participants Reporting at Least One Treatment-emergent Adverse Event (TEAE)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of Participants With Clinically Significant Abnormal Laboratory Parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of Participants With Clinically Significant Changes in 12-Lead Electrocardiogram (ECG) Findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of Participants With Clinically Significant Abnormal Vital Signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight-for-age z-score (WAZ) at 30 days of age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Arterial Pressure (MAP) concordance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Necrosis of tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Patient Health Outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptomatic intracranial hemorrhagic transformation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Percentage of eyes with monocular UDVA of logMAR -0.10 (20/16)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained abstinence (Month 6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Longest duration of abstinence (Month 6)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Bubble Inclinometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sternocleidomastoid muscle Ultrasonography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eligible participants who agreed to participate
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of participants with CGM use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived satisfaction of SMA intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative complete hematologic response (CHR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Mediterranean Diet Assessment Tool (14-MEDAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: cancer detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of time target blood pressure falls outside specified ranges
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of hemodynamic unstability events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of patients with hemodynamic unstability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Anesthesiologist's satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correction of coagulopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: self-management among diabetics
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: effective management of diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subjective stress perception
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: non-alcoholic fatty liver disease prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes of arterial blood gases (ABG) parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: duration of ventilatory support
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: delay between admission and intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of life (FACT-B)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Adverse events associated with KRG administration
Endpoint domain: Adverse events/effects
Primary endpoint: 6-month echocardiographic response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Days for oral intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative urine leak
Endpoint domain: Adverse events/effects
Primary endpoint: Stone-free status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Percentage of pregnant women with maternal adverse events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of pregnant women with obstetrical AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of pregnant women with pregnancy AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative analgesic use
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pediatric Nausea Assessment Tool (PeNAT)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of patients that found treatment satisfactory
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Impact on treatment decisions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Forward propulsion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Orthopedic Foot and Ankle Society questionnaire (AOFAS)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pittsburgh Foot Survey
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Manchester Foot and Ankle Disability Index
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mayo Clinical Scoring System questionnaire (MAYO)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Foot and Ankle Ability Measure (FAAM) questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in condom use self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Frequency of condomless anal intercourse (CAS) without protection by PrEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Youth self-report of being current on HIV testing
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Clinical Performance Assessed by Colposcopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of treatment-related Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Aria Under Receiver Operating Characteristic (ROC) Curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food Challenge Positive Reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Blood Glucose iAUC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduced waist circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduced serum triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: postprandial triglyceride
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of weekly connections of epileptic patients
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Overall impact on patient's quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence rate of treatment-emergent alopecia
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of perinatal mortality
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of operative delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Indication for operative delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Oxygenated haemoglobin concentration (HbO)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the concentration time curve from time zero to time infinity (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients discharged home from ED
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Sleep Disturbance Inventory (SDI)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Percentage of patients with undetectable minimal residual disease at cycle 16 (peripheral blood)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with undetectable minimal residual disease at cycle 16 (bone marrow aspirate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eligible patients with undetectable minimal residual disease at cycle 23 (peripheral blood)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of eligible patients with undetectable minimal residual disease at cycle 23 (bone marrow aspirate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Systemic ventricular end-diastolic volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Systemic ventricular end-systolic volume index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of patients achieving 75% improvement in PASI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Complete Response (CR) rate at 6 months
Endpoint domain: Mortality/survival
Primary endpoint: Complete Response (CR) rate at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Rate of heart failure occurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Desensitization to qualifying food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OUD severity (DSM-5 criteria)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive function (TMT-B)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Brain function (peak frequency)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Brain function (power spectrum)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Glycemic response to beef and impossible beef diet
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dehydroepiandrosterone sulfate (DHEA-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 17-hydroxyprogesterone (17-OH progesterone)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Sense of competence of the professional caregiver
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Systolic Blood Pressure (SBP) Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Alkaline Phosphatase level in saliva and GCF
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of cases with hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Accuracy of tumour staging diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change from baseline of SLEDAI-2K score at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adverse events related to IM19 CAR-T cell therapy
Endpoint domain: Adverse events/effects
Primary endpoint: N2 nodal clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes